These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29908083)

  • 1. Greater severity of peanut challenge reactions using a high-fat vs low-fat matrix vehicle.
    Pettersson ME; Koppelman GH; Schins AMM; van Ginkel CD; Flokstra-de Blok BMJ; Kollen BJ; Dubois AEJ
    Clin Exp Allergy; 2018 Oct; 48(10):1364-1367. PubMed ID: 29908083
    [No Abstract]   [Full Text] [Related]  

  • 2. Intentional poisoning with peanut as a cause of recurrent anaphylaxis.
    Robertson K; Kim H
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):622-623. PubMed ID: 32142908
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
    Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
    J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization.
    Bird JA; Feldman M; Arneson A; Dougherty I; Brown LS; Burk CM; Kulis M; Burks W; Gill M
    J Allergy Clin Immunol Pract; 2015; 3(3):433-5.e1-3. PubMed ID: 25609341
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction of peanuts in younger siblings of children with peanut allergy: a prospective, double-blinded assessment of risk, of diagnostic tests, and an analysis of patient preferences.
    Bégin P; Graham F; Killer K; Paradis J; Paradis L; Des Roches A
    Allergy; 2016 Dec; 71(12):1762-1771. PubMed ID: 27291651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ
    Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The component-specific to total IgE ratios do not improve peanut and hazelnut allergy diagnoses.
    Grabenhenrich L; Lange L; Härtl M; Kalb B; Ziegert M; Finger A; Harandi N; Schlags R; Gappa M; Puzzo L; Stephan V; Heigele T; Büsing S; Ott H; Niggemann B; Beyer K
    J Allergy Clin Immunol; 2016 Jun; 137(6):1751-1760.e8. PubMed ID: 27087317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.
    Kulis M; Saba K; Kim EH; Bird JA; Kamilaris N; Vickery BP; Staats H; Burks AW
    J Allergy Clin Immunol; 2012 Apr; 129(4):1159-62. PubMed ID: 22236732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three peanut-allergic/sensitized phenotypes with gender difference.
    Just J; Elegbede CF; Deschildre A; Bousquet J; Moneret-Vautrin DA; Crepet A;
    Clin Exp Allergy; 2016 Dec; 46(12):1596-1604. PubMed ID: 27512923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Ara h 2 sIgE levels to predict peanut allergy in Canadian children.
    Leo SH; Dean JM; Jung B; Kuzeljevic B; Chan ES
    J Allergy Clin Immunol Pract; 2015; 3(6):968-9. PubMed ID: 25939537
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
    Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
    Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
    J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peanut allergy-Individual molecules as a key to precision medicine.
    Jappe U; Breiteneder H
    Allergy; 2019 Feb; 74(2):216-219. PubMed ID: 30281802
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic Capacity of Commercial Extracts vs Prick-by-Prick in the Study of Sensitization to Peanut: Which Technique Should We Use?
    D'Amelio CM; García-Moral A; Bartra J; Azofra J; García Blanca E; Quiñones MD; Goikoetxea MJ; Martínez-Aranguren R; Gastaminza G
    J Investig Allergol Clin Immunol; 2020; 30(5):373-375. PubMed ID: 32376516
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of peanut matrix on stability of allergens in gastric-simulated digesta: 2S albumins are main contributors to the IgE reactivity of short digestion-resistant peptides.
    Prodic I; Stanic-Vucinic D; Apostolovic D; Mihailovic J; Radibratovic M; Radosavljevic J; Burazer L; Milcic M; Smiljanic K; van Hage M; Cirkovic Velickovic T
    Clin Exp Allergy; 2018 Jun; 48(6):731-740. PubMed ID: 29412488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Unexpected Consequence of a Clinical Trial.
    Bushyhead D; Dorer RK; Gluck M
    Gastroenterology; 2019 Oct; 157(4):944-945. PubMed ID: 30615868
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions.
    Gomez F; Bogas G; Gonzalez M; Campo P; Salas M; Diaz-Perales A; Rodriguez MJ; Prieto A; Barber D; Blanca M; Torres MJ; Mayorga C
    Clin Exp Allergy; 2017 Mar; 47(3):339-350. PubMed ID: 28160513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended boiling of peanut progressively reduces IgE allergenicity while retaining T cell reactivity.
    Tao B; Bernardo K; Eldi P; Chegeni N; Wiese M; Colella A; Kral A; Hayball J; Smith W; Forsyth K; Chataway T
    Clin Exp Allergy; 2016 Jul; 46(7):1004-14. PubMed ID: 27079163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of peanut-specific IgE levels in predicting the outcome of double-blind, placebo-controlled food challenges.
    van Nieuwaal NH; Lasfar W; Meijer Y; Kentie PA; Flinterman AE; Pasmans SG; Knulst AC; Hoekstra MO
    J Allergy Clin Immunol; 2010 Jun; 125(6):1391-2. PubMed ID: 20304474
    [No Abstract]   [Full Text] [Related]  

  • 20. Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in mice.
    Johnson-Weaver BT; Sempowski GD; Staats HF
    Allergy; 2019 Nov; 74(11):2220-2223. PubMed ID: 30746720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.